CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions
CRESTONE:一项评估HER3单克隆抗体Seribantumab治疗伴有Neuregulin-1 (NRG1)融合的实体瘤的疗效和安全性的II期研究
期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-25-00221
Patil, Tejas; Lin, Jessica J; Cheema, Parneet K; Carrizosa, Daniel R; Burkard, Mark E; Elamin, Yasir Y; Desai, Jayesh; Patel, Jyoti D; Nagasaka, Misako; Reckamp, Karen L; Waqar, Saiama N; Bauman, Jessica R; Schram, Alison M; Gadgeel, Shirish M; Ma, Patrick C; Konduri, Kartik; Nguyen, Danny; Misleh, Jamal; Bleeker, Jonathan; Weiss, Matthias; Thavaneswaran, Subotheni; Haura, Eric B; Deegan, Maegan; Kaufman, Jonathan; Srivastava, Jaya; Jansen, Valerie M; Liu, Stephen V